Document is current
Any future updates will be listed below
-
Authors
Leonardi, Andrea https://orcid.org/0000-0002-7246-8580
Doan, Serge
Aragona, Pasquale
Amrane, Mourad
Ismail, Dahlia
Montero, Jesús
Németh, János https://orcid.org/0000-0001-8575-4888
Bremond-Gignac, Dominique
-
Funding
Funding for this research was provided by:
Santen
- License Information
-
More Information
Article History
Received: 1 July 2022
Revised: 28 October 2022
Accepted: 30 November 2022
First Online: 23 December 2022
Competing interests
: AL is a consultant for Alcon, Bausch & Lomb, Santen Pharmaceutical Co. Ltd., Keridon, Laboratoires Théa, URSA-pharma, Seqirus, SIFI, SOOFT-Fidia; SD is a consultant for Horus Pharma, Santen Pharmaceutical Co. Ltd., Alcon, Allergan, Bausch & Lomb, and Laboratoires Théa; PA is a consultant or has received financial support from Alcon Italia, Allergan, Bausch & Lomb, DMG Italia, Medivis, Novartis, Offhealth, Santen Italia, SIFI S.p.A, Fidia-Sooft, and Laboratoires Théa; MA is an employee of Santen SAS France; DI is an employee of Santen SAS France; JM has been a consultant for Brill Pharma, Santen Pharmaceutical Co. Ltd., Alcon, Bausch & Lomb, Sifi, Laboratoires Théa; JN has no financial disclosure to declare; DBG is a consultant for Novartis, Santen Pharmaceutical Co. Ltd., Alcon, Allergan, Bausch & Lomb, and Laboratoires Théa.
